Spots Global Cancer Trial Database for Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
Official Title: Tele-Navigation of Lung Cancer Screening
Study ID: NCT05021133
Conditions
Interventions
Study Description
Brief Summary: Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UMass Chan Medical School, Worcester, Massachusetts, United States
Contact Details
Name: Mayuko Ito Fukunaga, MD
Affiliation: University of Massachusetts, Worcester
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
